U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children

AUVI-Q® (epinephrine injection, USP) 0.1 mg could be the first auto-injector approved with a needle length and dose specifically designed for infants and small children Emergency room visits due to anaphylaxis are increasing in children RICHMOND,... Biopharmaceuticals, Devices, Drug Delivery, FDA Kaléo, epinephrine, auto-injector
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news